Search Results - "CHEVALLIER, Bernard"

Results of a European Organization for Research and Treatment of Cancer/Early Clinical Studies Group Phase II Trial of First-Line Irinotecan in Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Cervix by LHOMME, C, FUMOLEAU, P, LENTZ, M.-A, VAN GLABBEKE, M, MATTHIEU-BOUE, A, MIGNARD, D, CHEVALLIER, B, FARGEOT, P, KRAKOWSKI, Y, DIERAS, V, CHAUVERGNE, J, VENNIN, P, REBATTU, P, ROCHE, H, MISSET, J.-L

“…To determine the efficacy and tolerability of irinotecan (CPT-11) in advanced or recurrent cervical carcinoma. Eligible patients had histologically confirmed,…”
Get full text

Inflammatory breast cancer. Determination of prognostic factors by univariate and multivariate analysis by Chevallier, B, Asselain, B, Kunlin, A, Veyret, C, Bastit, P, Graic, Y

“…Between January 1977 and June 1983, 64 consecutive patients were treated for unilateral inflammatory nonmetastatic breast cancer. Our protocol included three…”
Get more information

Inflammatory breast cancer outcome with epirubicin-based induction and maintenance chemotherapy : Ten-year results from the french adjuvant study group GETIS 02 trial by VEYRET, Corinne, LEVY, Christelle, CHOLLET, Philippe, MERROUCHE, Yacine, ROCHE, Henri, KERBRAT, Pierre, FUMOLEAU, Pierre, FARGEOT, Pierre, CLAVERE, Pierre, CHEVALLIER, Bernard

“…The authors evaluated the long-term efficacy and side effects in patients with nonmetastatic, unilateral, inflammatory breast cancer (IBC) who received…”
Get full text

Abstract 2564: No Late and no Very Late Stent Thrombosis with a Drug-Eluting Stent of the Second Generation: 2 Years Results from the Randomized NOBORI-I Trial by Silber, Sigmund, Chevallier, Bernard, Serruys, Patricl, Garcia, E., Maranon, Gregorio, Suryapranata, Harry, Klinieken, Isala

“…Abstract only Background: Late (after 30 days to 1 year) and very late (after 1 year) stent thrombosis is a continuous concern for drug-eluting stents (DES) of…”
Get full text

Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer by Bruno, R, Hille, D, Riva, A, Vivier, N, ten Bokkel Huinnink, W W, van Oosterom, A T, Kaye, S B, Verweij, J, Fossella, F V, Valero, V, Rigas, J R, Seidman, A D, Chevallier, B, Fumoleau, P, Burris, H A, Ravdin, P M, Sheiner, L B

“…The population pharmacokinetic/pharmacodynamic (PK/PD) approach was prospectively integrated in the clinical development of docetaxel to assess the PK profile…”
Get more information

Inflammatory breast cancer outcome with epirubicin‐based induction and maintenance chemotherapy by Veyret, Corinne, Levy, Christelle, Chollet, Philippe, Merrouche, Yacine, Roche, Henri, Kerbrat, Pierre, Fumoleau, Pierre, Fargeot, Pierre, Clavere, Pierre, Chevallier, Bernard

“…BACKGROUND. The authors evaluated the long‐term efficacy and side effects in patients with nonmetastatic, unilateral, inflammatory breast cancer (IBC) who…”
Get full text

Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer by Chevallier, B, Fumoleau, P, Kerbrat, P, Dieras, V, Roche, H, Krakowski, I, Azli, N, Bayssas, M, Lentz, M A, Van Glabbeke, M

“…This trial investigated the toxicity and efficacy of docetaxel as first-line chemotherapy in women with heavily pretreated advanced breast cancer. From April…”
Get more information

Inflammatory breast cancer. Pilot study of intensive induction chemotherapy (FEC-HD) results in a high histologic response rate by Chevallier, B, Roche, H, Olivier, J P, Chollet, P, Hurteloup, P

“…Between July 1988 and May 1990, we treated 45 women with newly diagnosed, unilateral, nonmetastatic, inflammatory breast cancer with an intensive neoadjuvant…”
Get more information

Lenograstim prevents morbidity from intensive induction chemotherapy in the treatment of inflammatory breast cancer by Chevallier, B, Chollet, P, Merrouche, Y, Roche, H, Fumoleau, P, Kerbrat, P, Genot, J Y, Fargeot, P, Olivier, J P, Fizames, C

“…To compare the efficacy and safety of recombinant human granulocyte colony-stimulating factor (rHuG-CSF) versus its inert vehicle in patients with unilateral…”
Get more information

Efficacy of lenograstim on hematologic tolerance to MAID chemotherapy in patients with advanced soft tissue sarcoma and consequences on treatment dose-intensity by Bui, B N, Chevallier, B, Chevreau, C, Krakowski, I, Peny, A M, Thyss, A, Maugard-Louboutin, C, Cupissol, D, Fargeot, P, Bonichon, F

“…This two-arm, double-blind, randomized trial was conducted to determine the effects of lenograstim, a glycosylated recombinant human granulocyte…”
Get more information

Serum hyaluronan (hyaluronic acid) in breast cancer patients by Delpech, B, Chevallier, B, Reinhardt, N, Julien, J P, Duval, C, Maingonnat, C, Bastit, P, Asselain, B

“…Eighty-three women with breast cancer (57 with systemic metastasis, 26 without) were investigated for serum hyaluronan (HA) and compared to 50 patients with…”
Get more information

Prognostic value of estrogen and progesterone receptors in operable breast cancer. Results of a univariate and multivariate analysis by Chevallier, B, Heintzmann, F, Mosseri, V, Dauce, J P, Bastit, P, Graic, Y, Brunelle, P, Basuyau, J P, Comoz, M, Asselain, B

“…From October 1977 to December 1983, estrogen receptor (ER) and progesterone receptor (PR) levels were measured in 645 tumors from women with primary,…”
Get more information

Phase I-II trial of intensification of the MAID regimen with support of lenograstim (rHuG-CSF) in patients with advanced soft-tissue sarcoma (STS) by CHEVREAU, C, BINH NGUYEN BUI, CHEVALLIER, B, KRAKOWSKI, I, MAUGARD, C, MIHURA, J, COINDRE, J. M, GIL, B, COUR-CHABERNAUD, V

“…This study was conducted to determine the maximum tolerated dose of an intensified MAID (mesna, adriamycin, ifosfamide, dacarbazine) regimen with the support…”
Get full text

A clinical Screening Cooperative Group phase II evaluation of lobaplatin (ASTA D-19466) in advanced head and neck cancer by DEGARDIN, M, ARMAND, J. P, CHEVALLIER, B, CAPPELAERE, P, LENTZ, M.-A, DAVID, M, ROCHE, H

“…We evaluated the efficacy and tolerability of lobaplatin, a new platinum compound, given at the dose of 50 mg/m2 by i.v. bolus every 4 weeks, in 49 patients…”
Get full text

Napoleon invades America by Chevallier, Bernard

“…Napoleon Bonaparte, his military and imperial nature and his mark on history are discussed. A look at paintings, sculpture and other items featured in an…”
Get full text

Tamoxifen for the treatment of metastatic inflammatory breast carcinoma by Atlan, D, Chevallier, B, Sheng, R G

“…In this series, 65 patients with metastatic inflammatory breast carcinoma were treated with neoadjuvant chemotherapy followed by local regional treatment…”
Get more information